CRISPR Therapeutics AG Revenue 2015-2025 | CRSP

CRISPR Therapeutics AG revenue for the twelve months ending March 31, 2025 was $0.038B, a 86.13% decline year-over-year.

  • CRISPR Therapeutics AG annual revenue for 2024 was $0.037B, a 89.95% decline from 2023.
  • CRISPR Therapeutics AG annual revenue for 2023 was $0.371B, a 30885.48% increase from 2022.
  • CRISPR Therapeutics AG annual revenue for 2022 was $0.001B, a 99.87% decline from 2021.

CRISPR Therapeutics AG Revenue 2015-2025 | CRSP

  • CRISPR Therapeutics AG annual revenue for 2024 was $0.037B, a 89.95% decline from 2023.
  • CRISPR Therapeutics AG annual revenue for 2023 was $0.371B, a 30885.48% increase from 2022.
  • CRISPR Therapeutics AG annual revenue for 2022 was $0.001B, a 99.87% decline from 2021.